David Stryker, MD
Infectious Disease · Albuquerque, NMNPI 1598725434
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,649 of the $1,907 with a category attached, or 86.5%. 14 manufacturers reported payments, led by AbbVie at 25.8% of the total. Reporting peaked in 2019 at $862 and has fallen 97.7% since, to $20 in 2024.
Across 91 payments — averaging $20.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$491
- Astellas Pharma US Inc$422
- Gilead$254
- Viiv Healthcare Company$245
- Merck$182
- Insmed, Inc.$85
- plus $228 from 8 others
What the payments were for
- Food & beverage$1,64987%
- Education$25713%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 21 | $491 |
| Astellas Pharma US Inc | 15 | $422 |
| Gilead | 9 | $254 |
| Viiv Healthcare Company | 13 | $245 |
| Merck | 14 | $182 |
| Insmed, Inc. | 5 | $85 |
| GSK | 6 | $75 |
| Smith+Nephew | 2 | $42 |
| Bsn Medical Inc | 1 | $29 |
| Cumberland Pharmaceuticals, Inc. | 1 | $20 |
| Philips North America LLC | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| Nabriva Therapeutics, PLC | 1 | $13 |
| Dynavax Technologies Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,907 in reported general payments places this provider in the 70th percentile of 31 infectious disease providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Albuquerque
- Cathy PettiAlbuquerque$29K
- Jeffrey RossAlbuquerque$5K
- Thomas RobertsAlbuquerque$5K
- Mohamed Al KatebAlbuquerque$2K
- Felix CernaAlbuquerque$2K
- Jorge Soria MoncadaAlbuquerque$2K
- Christine BoehringerAlbuquerque$1K
- Robert ParsonsAlbuquerque$1K
- Harshdeep BabbarAlbuquerque$1K
- Kory TilleryAlbuquerque$937
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.